• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外优化成熟骨髓来源树突状细胞的生成:析因研究设计

Optimizing the generation of mature bone marrow-derived dendritic cells in vitro: a factorial study design.

作者信息

Alotaibi Najla, Aldahlawi Alia, Zaher Kawther, Basingab Fatemah, Alrahimi Jehan

机构信息

Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Immunology Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

J Genet Eng Biotechnol. 2023 Nov 29;21(1):144. doi: 10.1186/s43141-023-00597-4.

DOI:10.1186/s43141-023-00597-4
PMID:38017248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10684437/
Abstract

BACKGROUND

Factorial design is a simple, yet elegant method to investigate the effect of multiple factors and their interaction on a specific response simultaneously. Hence, this type of study design reaches the best optimization conditions of a process. Although the interaction between the variables is widely prevalent in cell culture procedures, factorial design per se is infrequently utilized in improving cell culture output. Therefore, we aim to optimize the experimental conditions for generating mature bone marrow-derived dendritic cells (BMDCs). Two different variables were investigated, including the concentrations of the inducing factors and the starting density of the bone marrow mononuclear cells. In the current study, we utilized the design of experiments (DoE), a statistical approach, to systematically assess the impact of factors with varying levels on cell culture outcomes. Herein, we apply a two-factor, two-level (2) factorial experiment resulting in four conditions that are run in triplicate. The two variables investigated here are cytokines combinations with two levels, granulocyte-macrophage colony-stimulating factor (GM-CSF) alone or with interleukin-4 (IL4). The other parameter is cell density with two different concentrations, 2 × 10 and 4 × 10 cells/mL. Then, we measured cell viability using the trypan blue exclusion method, and a flow cytometer was used to detect the BMDCs expressing the markers FITC-CD80, CD86, CD83, and CD14. BMDC marker expression levels were calculated using arbitrary units (AU) of the mean fluorescence intensity (MFI).

RESULTS

The current study showed that the highest total viable cells and cells yield obtained were in cell group seeded at 2 × 10 cells/mL and treated with GM-CSF and IL-4. Importantly, the expression of the co-stimulatory molecules CD83 and CD80/CD86 were statistically significant for cell density of 2 × 10 cells/mL (P < 0.01, two-way ANOVA). Bone marrow mononuclear cells seeded at 4 × 10 in the presence of the cytokine mix less efficiently differentiated and matured into BMDCs. Statistical analysis via two-way ANOVA revealed an interaction between cell density and cytokine combinations.

CONCLUSION

The analysis of this study indicates a substantial interaction between cytokines combinations and cell densities on BMDC maturation. However, higher cell density is not associated with optimizing DC maturation. Notably, applying DoE in bioprocess designs increases experimental efficacy and reliability while minimizing experiments, time, and process costs.

摘要

背景

析因设计是一种简单而精巧的方法,可同时研究多个因素及其相互作用对特定反应的影响。因此,这种研究设计能够达到一个过程的最佳优化条件。尽管变量之间的相互作用在细胞培养过程中广泛存在,但析因设计本身在提高细胞培养产量方面却很少被使用。因此,我们旨在优化生成成熟骨髓来源树突状细胞(BMDCs)的实验条件。我们研究了两个不同的变量,包括诱导因子的浓度和骨髓单个核细胞的起始密度。在本研究中,我们采用实验设计(DoE)这一统计方法,系统地评估不同水平的因素对细胞培养结果的影响。在此,我们进行了一个双因素、两水平(2²)析因实验,产生四种条件,并重复进行三次。这里研究的两个变量是具有两个水平的细胞因子组合,单独的粒细胞 - 巨噬细胞集落刺激因子(GM - CSF)或与白细胞介素 - 4(IL4)组合。另一个参数是具有两种不同浓度(2×10⁶和4×10⁶个细胞/mL)的细胞密度。然后,我们使用台盼蓝排斥法测量细胞活力,并使用流式细胞仪检测表达标记物FITC - CD80、CD86、CD83和CD14的BMDCs。BMDC标记物表达水平使用平均荧光强度(MFI)的任意单位(AU)进行计算。

结果

本研究表明,接种密度为2×10⁶个细胞/mL并接受GM - CSF和IL - 4处理的细胞组获得的总活细胞数和细胞产量最高。重要的是,对于接种密度为2×10⁶个细胞/mL的细胞,共刺激分子CD83和CD80/CD86的表达具有统计学意义(P < 0.01,双向方差分析)。在细胞因子混合物存在下,接种密度为4×10⁶个细胞/mL的骨髓单个核细胞分化和成熟为BMDCs的效率较低。通过双向方差分析进行的统计分析揭示了细胞密度和细胞因子组合之间的相互作用。

结论

本研究分析表明,细胞因子组合与细胞密度在BMDC成熟过程中存在显著相互作用。然而,较高的细胞密度与优化DC成熟无关。值得注意的是,在生物过程设计中应用DoE可提高实验效率和可靠性,同时最大限度地减少实验、时间和过程成本。

相似文献

1
Optimizing the generation of mature bone marrow-derived dendritic cells in vitro: a factorial study design.体外优化成熟骨髓来源树突状细胞的生成:析因研究设计
J Genet Eng Biotechnol. 2023 Nov 29;21(1):144. doi: 10.1186/s43141-023-00597-4.
2
Bothrops jararacussu snake venom decreases CD1d, CD83, and CD86 expression on bone marrow-derived dendritic cells.矛头蝮蛇蛇毒可降低骨髓来源树突状细胞表面 CD1d、CD83 和 CD86 的表达。
Immunol Lett. 2023 Oct;262:7-17. doi: 10.1016/j.imlet.2023.08.003. Epub 2023 Aug 26.
3
Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.通过与粒细胞巨噬细胞集落刺激因子、白细胞介素-4和肿瘤坏死因子-α共同培养,从脐血贴壁细胞生成树突状细胞。
J Hematother Stem Cell Res. 2000 Aug;9(4):453-64. doi: 10.1089/152581600419116.
4
[Expression of CC-chemokine ligand 18 (CCL18) in the serum and pleural effusion of non-small-cell lung cancer patients and its regulatory effect on the differentiation of monocyte-derived dendritic cells].非小细胞肺癌患者血清及胸腔积液中CC趋化因子配体18(CCL18)的表达及其对单核细胞来源树突状细胞分化的调节作用
Zhonghua Zhong Liu Za Zhi. 2014 Nov;36(11):823-7.
5
Systematic evaluation of the conditions required for the generation of immature rat bone marrow-derived dendritic cells and their phenotypic and functional characterization.对未成熟大鼠骨髓来源树突状细胞生成所需条件及其表型和功能特性的系统评估。
J Immunol Methods. 2004 Nov;294(1-2):165-79. doi: 10.1016/j.jim.2004.09.006. Epub 2004 Oct 12.
6
[In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].[慢性髓性白血病骨髓单个核细胞的体外诱导分化]
Ai Zheng. 2005 Apr;24(4):425-31.
7
Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment.通过两步培养结合钙离子载体处理从脐血和骨髓CD34+细胞生成功能性成熟树突状细胞。
J Immunol Methods. 2002 Mar 1;261(1-2):49-63. doi: 10.1016/s0022-1759(01)00545-2.
8
Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.体外培养持续时间对外周血单核细胞来源的成熟树突状细胞的表型和细胞因子产生的影响。
Transfusion. 2009 Mar;49(3):536-47. doi: 10.1111/j.1537-2995.2008.02020.x.
9
[In vitro cytokines-induced differentiation in mononuclear cell derived dendritic cells from chronic myeloid leukemia].[慢性髓性白血病单核细胞来源树突状细胞的体外细胞因子诱导分化]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Feb;14(1):137-41.
10
Maturation inside and outside bone marrow dendritic cells (BMDCs) modulated by interferon-α (IFN-α).骨髓树突状细胞(BMDCs)内、外成熟受干扰素-α(IFN-α)调节。
Int Immunopharmacol. 2013 Nov;17(3):843-9. doi: 10.1016/j.intimp.2013.09.011. Epub 2013 Oct 3.

本文引用的文献

1
Dendritic cells trigger imbalance of Th1/Th2 cells in silica dust exposure rat model MHC-II, CD80, CD86 and IL-12.在二氧化硅粉尘暴露大鼠模型中,树突状细胞引发Th1/Th2细胞失衡、主要组织相容性复合体II类分子、CD80、CD86和白细胞介素-12。
RSC Adv. 2018 Jul 20;8(46):26108-26115. doi: 10.1039/c8ra03970d. eCollection 2018 Jul 19.
2
Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination.胃癌中的细胞免疫疗法:过继性细胞疗法和基于树突状细胞的疫苗接种
Immunotherapy. 2022 Apr;14(6):475-488. doi: 10.2217/imt-2021-0285. Epub 2022 Mar 2.
3
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial.
基于树突状细胞的免疫疗法 DCVAC/OvCa 联合一线化疗(卡铂联合紫杉醇)治疗上皮性卵巢癌的安全性和有效性:一项 2 期、开放标签、多中心、随机临床试验。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003190.
4
Distribution and maturation state of peripheral blood dendritic cells in children with primary hypertension.原发性高血压患儿外周血树突状细胞的分布与成熟状态。
Hypertens Res. 2022 Mar;45(3):401-413. doi: 10.1038/s41440-021-00809-9. Epub 2021 Dec 16.
5
Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial.树突细胞疫苗联合常规化疗治疗复发或晚期胰腺导管腺癌患者的单中心 I/II 期试验。
Ther Apher Dial. 2021 Aug;25(4):415-424. doi: 10.1111/1744-9987.13659. Epub 2021 May 14.
6
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells.用于癌症免疫治疗的树突状细胞疫苗:人常规1型树突状细胞的作用
Pharmaceutics. 2020 Feb 15;12(2):158. doi: 10.3390/pharmaceutics12020158.
7
Cystatin C regulates major histocompatibility complex-II-peptide presentation and extracellular signal-regulated kinase-dependent polarizing cytokine production by bone marrow-derived dendritic cells.胱抑素 C 通过调节主要组织相容性复合体 II-肽呈递和细胞外信号调节激酶依赖性极化细胞因子产生来调节骨髓来源树突状细胞。
Immunol Cell Biol. 2019 Nov;97(10):916-930. doi: 10.1111/imcb.12290. Epub 2019 Oct 15.
8
Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.采用析因设计优化尼美舒利固体脂质纳米粒(SLN)的载药量、释放特性和对人结肠腺癌细胞系的细胞毒性。
Pharm Dev Technol. 2019 Jun;24(5):616-622. doi: 10.1080/10837450.2018.1549075. Epub 2019 Jan 4.
9
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity.1型常规树突状细胞在癌症免疫中的作用。
Trends Cancer. 2018 Nov;4(11):784-792. doi: 10.1016/j.trecan.2018.09.001. Epub 2018 Sep 29.
10
The importance of factorial design in tissue engineering and biomaterials science: Optimisation of cell seeding efficiency on dermal scaffolds as a case study.析因设计在组织工程和生物材料科学中的重要性:以优化真皮支架上的细胞接种效率为例
J Tissue Eng. 2018 Jun 25;9:2041731418781696. doi: 10.1177/2041731418781696. eCollection 2018 Jan-Dec.